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Abstract
 
Mice lacking the membrane tyrosine kinase c-mer have been shown to have altered macro-
phage cytokine production and defective phagocytosis of apoptotic cells despite normal phago-
cytosis of other particles. We show here that c-mer–deficient mice have impaired clearance of
infused apoptotic cells and that they develop progressive lupus-like autoimmunity, with anti-
bodies to chromatin, DNA, and IgG. The autoimmunity appears to be driven by endogenous
antigens, with little polyclonal B cell activation. These mice should be an excellent model for
studying the role of apoptotic debris as an immunogenic stimulus for systemic autoimmunity.
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Introduction
 
Clearance of apoptotic cells is a critical function of the
mononuclear phagocyte system. Macrophages recognize
apoptotic cells through an array of surface receptors, among
them CD14, CD36, complement receptors, scavenger re-
ceptors, and a phosphatidylserine (PS)-specific receptor (1,
2). The phagocytosis and subsequent clearance of apoptotic
debris is remarkably rapid and efficient: even in the thymus
of young mice, where debris is generated at a great rate,
apoptotic bodies can be visualized only with special meth-
ods (3). The redundancy of the clearance system is illus-
trated by apparently normal clearance and by the absence of
in vivo apoptotic bodies in most receptor knockout mod-
els, with the exceptions of the C1q-deleted mouse (4); and
mice with a targeted disruption of the cytoplasmic region
of the membrane tyrosine kinase c-mer (5, 6).
The membrane tyrosine kinase c-mer is believed to bind
to the protein GAS6, which in turn can bind to PS (7).
Mice lacking the intracellular domain of c-mer show in-
creased LPS-induced TNF-
 
 
 
 production and suffer in-
creased mortality after LPS administration in vivo (5). They
have splenomegaly and identifiable apoptotic bodies within
lymphoid organs. We have recently shown that these 
 
mer
 
kd
 
mice have diminished in vivo clearance of apoptotic lym-
phocytes generated through corticosteroid administration
(6) and that this is due to a macrophage defect. Their mac-
rophages demonstrate impaired in vitro phagocytosis of
apoptotic lymphocytes, yet normal phagocytosis of other
particles. In our initial report, we indicated that the mac-
rophage defect was accompanied by increased levels of anti
native DNA antibodies. We report here that mice lacking
the intracellular kinase domain of c-mer show in vivo
delayed clearance of exogenously administered apoptotic
cells, and spontaneous development of additional serologi-
cal manifestations of systemic lupus. These include autoan-
tibodies to chromatin, IgG, and DNA, and development of
moderate renal pathology. These results and findings from
other models of diminished apoptotic clearance give fur-
ther weight to the notion that apoptotic cells provide an
immunogenic stimulus for autoimmunity, and that im-
paired clearance is an important factor in the pathogenesis
of systemic autoimmune disease.
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Materials and Methods
 
Mice.
 
Mice lacking the intracellular domain of c-mer (
 
mer
 
kd
 
)
were generated as described previously (5). The mice used were
backcrossed for 10 generations to C57BL/6 (B6) and were main-
tained in the SPF animal colonies at the University of North
Carolina, Chapel Hill; and at the University of Pennsylvania.
 
Immunoassays.
 
Antibodies to chromatin, IgG and single-
stranded DNA (ssDNA) were determined by ELISA as reported
previously. Briefly, chromatin was prepared from chicken eryth-
rocytes (8) and ssDNA from calf thymus (9). Plates were coated
with 3 
 
 
 
g/ml of antigen and washed. Diluted sera were added,
followed by biotin-conjugated developing antisera and then by
avidin-alkaline phosphatase (Sigma-Aldrich). Rheumatoid factor
(RF) was measured by coating plates with an IgG2b mouse my-
eloma protein, followed by development with biotin-labeled anti-
IgM. Total IgG was measured by ELISA as reported previously
(10). IgG and IgM anticardiolipin ELISAs were performed as de-
scribed previously for human sera (11) with the exception that al-
kaline phosphatase–conjugated goat anti–mouse IgG and alkaline
phosphatase-conjugated goat anti–mouse IgM antibodies (both
from Zymed Laboratories) were used as the secondary reagents.
 
Renal Pathology.
 
Kidneys were removed from mice of vari-
ous ages. One kidney from each mouse was processed for con-
ventional hematoxylin/eosin histology, while the other was snap-
frozen in liquid nitrogen. The frozen kidneys were sectioned
using a cryostat and stained for IgM, IgG, and C3 using fluoresce-
inated antibodies. Kidney pathology was scored as reported previ-
ously (12).
 
Immunization with Apoptotic Cells.
 
Spleen and thymus cells
were harvested and exposed to 1,500 R of gamma radiation from
a 
 
137
 
Cs source. 100 
 
  
 
10
 
6 
 
cells were injected intravenously weekly
for 4 wk as described previously (13). Mice were bled as indicated
and sera tested for anti-chromatin, anticardiolipin, and anti-DNA
antibodies.
 
Labeling of Apoptotic Cells.
 
Spleen and thymus cell suspen-
sions were exposed to 1,500 of gamma radiation, washed, and in-
cubated with the vital dye tetramethyl rhodamine phosphorami-
dite (TAMRA; Sigma-Aldrich; reference 14) for 30 min. After
washing, the labeled cells were injected intravenously into B6 or
 
mer
 
kd
 
 mice and spleens and lymph nodes harvested 14 h later.
Cells were examined using flow cytometry to identify TAMRA-
stained cells. In parallel to the in vivo studies, aliquots of the irra-
diated cells were followed for progression of apoptosis in vitro
using annexin V binding and DNA quantitation through propid-
ium iodide fluorescence. After 14 h, 100% of the cells were
apoptotic by these measures.
 
Statistical Analysis.
 
Levels of autoantibody production among
mouse groups were analyzed with the two-tailed Student’s 
 
t
 
 test.
 
P
 
 
 
 
 
 0.05 was considered significant. Data analysis was performed
with Microsoft Excel (1998) software.
 
Results
 
In Vivo Clearance of Apoptotic Cells Is Impaired in c-mer
 
kd
 
Mice.
 
Cells from 
 
mer
 
kd
 
 mice show decreased in vitro
phagocytosis of apoptotic cells, yet it was possible that in
vivo handling of exogenously administered apoptotic cells was
normal. To address this issue, we exposed freshly isolated
spleen and thymus cell suspensions to 500 R and labeled
them with TAMRA. These labeled preapoptotic cells were
infused intravenously into 
 
mer
 
kd
 
 or B6 mice and their pres-
ence was detected by immunofluorescence analysis of their
spleen cells after differing intervals. As seen in Fig. 1, in
 
mer
 
kd
 
 but not in normal mice there was a small but discrete
population of TAMRA-positive cells in the spleen at 14 h.
These results are representative of three experiments and in
each experiment at least two mice per group were used. In
addition to these apoptotic cells, we could also detect
TAMRA-labeled debris, indicating the persistence of cells
undergoing secondary necrosis. Apoptotic cells were not
observed in B6 recipients of apoptotic cells, nor was there
evidence in these mice of cells undergoing secondary ne-
crosis. We also looked at mice 2, 3, and 7 d after IV infu-
sion of TAMRA-labeled cells. In neither 
 
mer
 
kd
 
 nor in B6
mice were there any detectable TAMRA-labeled cells at
these later time points, indicating that clearance was even-
tually accomplished, even in the 
 
mer
 
kd
 
 animals.
 
Spontaneous Development of Anti-chromatin Antibodies in
mer
 
kd
 
 Mice.
 
A cohort of 
 
mer
 
kd
 
 mice was housed under spe-
cific pathogen-free conditions and bled at monthly inter-
vals. As seen in Fig. 2, many of these mice showed progres-
sively increased levels of autoantibodies to chromatin. The
autoantibody levels were equivalent to those found in B6/
lpr mice housed under similar conditions, but less than lev-
els seen in MRL/lpr mice. Similar results were observed
with two other cohorts of 
 
mer
 
kd
 
 mice examined earlier dur-
ing the derivation of the B6 congenic strain. It is notewor-
thy that, while autoantibody levels were highly significant,
only 30–50% developed anti-chromatin autoimmunity.
 
Mer
 
kd
 
 Mice Develop Autoantibodies to Single- and Double-
stranded DNA.
 
Antibodies to DNA are hallmarks of SLE
and antibodies to double-stranded (ds)DNA are consid-
Figure 1. Detection of apoptotic cells after infusion. 75–100   106
TAMRA-labeled apoptotic cells were given IV to merkd or B6 mice and
spleens removed 14 h later and analyzed using flow cytometry. Apoptotic
cells were identified by gating using forward and side scattering and are
denoted in the middle and bottom boxes (early and late apoptotic cells).
Red fluorescence of these populations is shown on the right, and depicts
TAMRA-labeled cells. This figure is representative of three experiments.
In each experiment at least two mice per group were used. Mean   SD
of all three experiments is shown. 
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ered nearly diagnostic of this disorder. As seen in Fig. 3,
 
mer
 
kd
 
 mice developed anti-ssDNA as they grew older. An-
tibodies to dsDNA were also observed in substantial num-
bers of mice (14/24 at 5 mo by 
 
Crithidia
 
 
 
luciliae
 
 immuno-
fluorescence assay; reference 5). There was little difference
in levels observed in females vs males for either specificity
(not shown).
 
Rheumatoid Factor Appears Late in Mer
 
kd
 
 Sera.
 
RF ac-
companies other serological features of SLE in some pa-
tients, and is known to be prominent in B6/lpr mice. As
shown in Fig. 4, 
 
mer
 
kd
 
 mice developed RF by 6–8 mo. As
has been reported for B6/lpr mice (15), RF levels were
greater in females. This autoantibody was primarily di-
rected at IgG2b; little reactivity was found against IgG1
(data not shown).
 
Autoimmunity in mer
 
kd
 
 Mice Is Not Accompanied by Poly-
clonal B Cell Activation.
 
Diffuse B cell activation accompa-
nies SLE-like autoantibody formation in several models of
murine systemic autoimmunity. To assess polyclonal anti-
body production, we measured total IgG levels by ELISA.
As shown in Fig. 5, there was a gradual increase with age of
IgG levels in both normal and 
 
mer
 
kd
 
 mice. The latter did
not show evidence of diffuse B cell activation. We also
quantitated polyclonal B cell activation using an enzyme-
linked immunospot (ELIspot) assay to enumerate splenic B
cells secreting IgG. The mean number of antibody-secret-
ing cells per 10
 
6 
 
spleen cells of four 5-mo-old 
 
mer
 
kd
 
 mice
was 3,230 
 
  
 
710, compared with 1,030 
 
 
 
 430 in four age-
matched B6 mice. This difference was of borderline statisti-
cal significance (
 
P
 
 
 
 
 
 0.051). Thus, the cell-based assay may
have detected a small degree of polyclonal B cell activation
in the 
 
mer
 
kd
 
 mice, though this may reflect the increased
amount of autoantibody secretion.
 
C-mer
 
kd
 
 Mice Develop Mild Renal Pathology Late in Life.
 
Our initial observations on 
 
mer
 
kd
 
 mice before extensive
backcrossing to B6 indicated that they developed severe lu-
pus-like focal membranoproliferative glomerulonephritis,
particularly females. After extensive backcrossing to B6, we
no longer observed severe renal disease. In contrast, 
 
mer
 
kd
 
mice on the B6 background developed mesangial lesions
Figure 2. Anti-chromatin in merkd and control mice. Mice aged from
2–10 mo were bled and serum analyzed by ELISA for anti-chromatin.
Results indicated ng/ml of specific antibody. Similar results were ob-
served in two other cohorts of mice. Asterisks indicate P   0.05 when
merkd mice were compared with B6 mice.
Figure 3. Anti-ssDNA in merkd and control mice. The same cohort of
mice shown in Fig. 2 was tested for anti-ssDNA by ELISA. Results are
reported as ng/ml of specific antibody.
Figure 4. Rheumatoid factor in merkd and control mice. The same sera
were tested for IgM antibody to IgG2b by ELISA. Results are representa-
tive of three experiments.
Figure 5. Total IgG in merkd and control mice. Total IgG was measured
by ELISA. 
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with deposition of modest amounts of C3, IgM, and IgG.
Kidneys from 18 6-mo-old 
 
mer
 
kd
 
 were examined micro-
scopically and immunofluorescence staining and blindly
graded from 0 to 4
 
 
 
. Only one mouse developed 3
 
 
 
 or
greater IgG staining. This was in a mesangial pattern, con-
sistent with light microscopic observations. This animal
also had 4
 
 
 
 IgM mesangial deposition. The mean IgG
staining for these 18 mice was 0.5
 
 
 
; IgA was 0.5
 
 
 
; IgM
1.3
 
 
 
; and C3 0.8
 
 
 
. Of 138 4 mo and older mice exam-
ined by dipstick, 19 had 2
 
 
 
 or greater proteinuria. These
findings are consistent with their apparent normal lifespan
and fecundity in our animal colony. It is likely that the 129
background genes contributed to the autoimmunity ob-
served before backcrossing.
 
Repeated Immunization of mer
 
kd
 
 Mice Accelerates Anti-cardio-
lipin But Not Anti-DNA Autoantibody Production.
 
It has
been reported that transient autoantibody production to
nuclear antigens and to phospholipids can be achieved
upon immunization of normal mice with apoptotic cells.
Because we hypothesized that 
 
mer
 
kd
 
 mice undergo self-
immunization with apoptotic cells, we asked whether the
infusion of exogenous apoptotic cells might lead to earlier or
to great amounts of autoantibody production. 
 
Mer
 
kd
 
 and B6
mice were given 10
 
7
 
 irradiated thymocytes, following the
protocol used by Mevorach and colleagues (13). Mice were
so immunized at 3 mo of age, and were bled at monthly
intervals. 5 of 10 apoptotic cell-immunized 
 
mer
 
kd
 
 mice
showed an increase in IgG anti-cardiolipin antibodies (dou-
bling or more of ELISA optical density [O.D.]), compared
with two of ten B6 controls. The mean baseline anti-car-
diolipin ELISA O.D. of the five 
 
mer
 
kd
 
 mice which evinced
an increase in O.D. was 0.128 
 
  
 
0.21; the peak response,
one month later was 0.347   0.132. IgM anti-cardiolipin
levels did not increase in any of the experimental groups. 2
of 10 apoptotic cell-immunized B6 mice showed an in-
crease at one month in IgG anti-cardiolipin antibody levels
(0.089   0.27 to 0.194   0.43). Neither anti-chromatin
nor anti-DNA antibody production was accelerated in im-
munized merkd mice compared with saline-injected controls
by 8 wk after immunization. In B6 recipients of apoptotic
cells, we noted no anti-DNA or anti-chromatin autoanti-
body production at any point sampled, including serum
collected as late as 12 wk after immunization.
Discussion
The principal findings of our study were that merkd mice
developed autoimmunity to nuclear antigens, accompanied
later on by rheumatoid factor. A defect in the rate of apop-
totic cell clearance was apparent in vivo, yet only anti-
phospholipid autoantibody production was accelerated
upon administration of apoptotic cells in vivo, indicating
that endogenous sources of apoptotic cells were sufficient
to provide the stimulus for most autoantibodies. It was
noteworthy that polyclonal B cell activation was not a fea-
ture of the autoimmune syndrome of the c-mer–deficient
mice. This may reflect the specific stimulus of autoantigen
in provoking autoantibodies, without concurrent stimula-
tion of nonautoreactive B cells.
Vast numbers of apoptotic cells are generated through cell
senescence, maturation, and turnover. Multiple macrophage
scavenger receptors serve the important function of recog-
nizing and promoting engulfment and removal of apoptotic
cells (2). Several recent reports have emphasized that defec-
tive macrophage clearance of apoptotic debris may lead to
autoimmunity. For instance, absence of C1q or of the CR2
receptor lead to autoimmunity, as does knocking out the
gene encoding serum amyloid protein and deletion of
DNase I (16). It has been proposed that these genetic ma-
nipulations, by altering the efficiency of clearance of apop-
totic cells, promote self-immunization with nuclear antigens
exposed in blebs on the surface of dying cells (17). While
direct proof of such self-immunization is not available, the
hypothesis is appealing and has been widely disseminated.
In support of the notion that apoptotic cells represent a
vehicle for potential autoimmunization, investigators have
documented modest transient antibody production in ani-
mals immunized with apoptotic cells (13). In other systems,
T cell reactivity to transfected antigens contained within
apoptotic cells in vivo and in vitro has been observed, and
is enhanced when appropriate costimulatory molecules and
cytokines are present (18, 19). The present findings are
consistent with the hypothesis that apoptotic cells represent
a potential source of autoantigens.
It was of interest that the effect of immunization with
apoptotic cells was evident only in increased anti-phospho-
lipid antibody titers, with little effect on anti-DNA or anti-
chromatin. This finding suggests that the continuous bur-
den of endogenous apoptotic cells is sufficient to drive the
immunization process in merkd mice; additional apoptotic
cells may add little to the immunization process. The in-
crease in anti-phospholipid antibodies may indicate a special
role for mer in the clearance of debris containing phospho-
lipids, perhaps via binding by mer (via GAS6) of phospho-
lipid-rich apoptotic bodies as has been suggested (20).
While absence of certain scavenger receptors results in
autoimmunity, mice without other receptors (SRS A,
CD36) do not develop an autoimmune phenotype despite
in vitro defects. What accounts for the autoimmunity in
merkd mice? One possibility is that the c-mer receptor is
more relevant for certain autoantigens than some of the
others. This hypothesis is supported by the observation of
accumulated apoptotic cells in merkd mice but not in SRS-
A–deficient animals in vivo. Another possibility is that
c-mer binds to apoptotic cells at a stage at which they are
more immunogenic. The expression of phosphatidylserine
on apoptotic cells is an early event, and is believed to medi-
ate binding via growth arrest specific protein 6 (GAS 6; ref-
erence 21) to c-mer. A failure to eliminate apoptotic cells
at this very early stage may lead to accumulation of late ap-
optotic cells and of cells undergoing secondary necrosis.
These cells may present a more immunogenic challenge
and may thus provoke autoantibody formation.
Another consideration for understanding autoimmunity
in merkd mice concerns the nature of our knockout mouse.139 Cohen et al. Brief Definitive Report
Because only the cytoplasmic domain of c-mer has been
removed, it is possible that merkd macrophages retain the
ability to bind apoptotic cells but not to internalize them.
Macrophage-bound apoptotic cells adherent to c-mer may
lead to cross priming and self-immunization. We think this
possibility unlikely because we have seen little if any c-mer
surface expression in merkd mice (unpublished data).
A final explanation for the autoimmune phenotype of
merkd mice deserves serious consideration. As initially re-
ported, c-mer serves an important role in regulating the cy-
tokine profile of macrophages. Macrophages from merkd
mice secrete larger amounts of TNF  than do control mac-
rophages, leading to increased LPS sensitivity (5). Others
have emphasized the key role of cytokine expression in
macrophages ingesting apoptotic cells. In contrast to their
secretion of inflammatory cytokines when confronted with
necrotic cells, macrophages ingesting apoptotic cells pro-
duce a panel of noninflammatory cytokines such as TGF 
and IL-10, thereby reducing the immunogenicity of apop-
totic cells (22). Merkd macrophages, in addition to their im-
paired clearance of apoptotic cells, may generate an inflam-
matory pattern of macrophage cytokine production. The
mice may therefore have both an increased burden of apop-
totic cells and a macrophage environment conducive to the
induction of T cell immunity to apoptotic cell antigens. The
combination of macrophage activation in an inflammatory
mode, together with persistence of late apoptotic cells and
possibly cells undergoing secondary necrosis, may present a
sufficient autoimmunogenic stimulus so that tolerance to
nuclear antigens is broken and autoimmunity ensues.
In support of the idea that macrophage activation is cru-
cial in promoting autoimmunity to apoptotic debris is a re-
cent report emphasizing the lymphoproliferative and auto-
immune phenotype of mice lacking c-mer, axl, and tyro-3.
These animals develop apparently higher levels of autoanti-
bodies to DNA than c-mer single knockouts, together with
other autoantibody specificities (23). The more severe au-
toimmunity in these animals may reflect their intense mac-
rophage activation, or may be due to a more severe apop-
totic clearance defect in the absence of all three members
of this receptor tyrosine kinase family.
The finding of autoimmunity in merkd mice opens the
way to new avenues to study the role of apoptotic debris as
an immunogenic stimulus in autoimmune disease. Macro-
phages from these mice, because of their delayed phagocy-
tosis of apoptotic cells, may make available nuclear antigens
to dendritic cells, as has been described in the MHC class I
pathway (24), and thereby generate immunogenic self-pep-
tide complexes in the context of MHC class II molecules.
We are currently devising model systems to assess disposi-
tion of apoptotic cell derived antigens in merkd mice. These
experiments should allow deduction of the role of apop-
totic cell uptake and macrophage cytokine production on
the presentation of nuclear autoantigens relevant to SLE.
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